{
    "id": "d74385e7-1d55-4cf8-90f7-f2e6343eb5f4",
    "indications": {
        "text": "bupivacaine hydrochloride dextrose injection , usp indicated subarachnoid injection adults production subarachnoid block ( spinal anesthesia ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "bupivacaine hydrochloride dextrose injection , usp administered varies anesthetic procedure , vascularity tissues , number neuronal segments blocked , depth anesthesia degree muscle relaxation required , duration anesthesia desired , individual tolerance , physical condition patient . administer smallest concentration required produce desired result . following general guidelines : bupivacaine hydrochloride dextrose injection , usp 6 mg generally adequate vaginal delivery . ( 2.2 ) bupivacaine hydrochloride dextrose injection , usp 7.5 mg generally adequate spinal anesthesia lower extremity perineal procedures . ( 2.2 ) bupivacaine hydrochloride dextrose injection , usp 12 mg generally adequate lower abdominal procedures . ( 2.2 ) bupivacaine hydrochloride dextrose injection , usp 7.5 mg 10.5 mg generally adequate cesarean section . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . [ usp controlled room temperature . ] bupivacaine hydrochloride dextrose injection , usp solution may autoclaved 15 pound pressure , 121\u00b0c ( 250\u00b0f ) 15 minutes . product clear colorless . solution discolored contains particulate matter . single-dose ampules 2 ml bupivacaine hydrochloride dextrose injection , usp ( 15 mg bupivacaine hydrochloride 165 mg dextrose ) supplied follows : unit sale concentration ndc 0264-9379-88 carton 10 single-dose ampules 15 mg/2 ml ( 7.5 mg/ml ) discard unused portion .",
    "adverseReactions": "bupivacaine hydrochloride dextrose injection contraindicated : intravenous regional anesthesia ( bier block ) [ ( 5.8 ) ] . patients septicemia . patients severe hemorrhage , severe hypotension shock , due reduced cardiac output . patients clinically significant arrhythmias , complete heartblock , due reduced cardiac output . patients known hypersensitivity bupivacaine local anesthetic agent amide-type components bupivacaine hydrochloride dextrose injection . patients local infection site proposed lumbar puncture .",
    "ingredients": [
        {
            "name": "BUPIVACAINE HYDROCHLORIDE",
            "code": "7TQO7W3VT8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3215"
        },
        {
            "name": "ANHYDROUS DEXTROSE",
            "code": "5SL0G7R0OK"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ],
    "organization": "B. Braun Medical Inc.",
    "name": "Bupivacaine Hydrochloride with Dextrose",
    "effectiveTime": "20241105",
    "indications_original": "Bupivacaine Hydrochloride in Dextrose Injection, USP is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia).",
    "contraindications_original": "The dosage of Bupivacaine Hydrochloride in Dextrose Injection, USP administered varies with the anesthetic procedure, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation required, the duration of anesthesia desired, individual tolerance, and the physical condition of the patient. Administer the smallest dosage and concentration required to produce the desired result. The following are general dosage guidelines: Bupivacaine Hydrochloride in Dextrose Injection, USP 6 mg is generally adequate for vaginal delivery. (2.2) Bupivacaine Hydrochloride in Dextrose Injection, USP 7.5 mg is generally adequate for spinal anesthesia for lower extremity and perineal procedures. (2.2) Bupivacaine Hydrochloride in Dextrose Injection, USP 12 mg is generally adequate for lower abdominal procedures. (2.2) Bupivacaine Hydrochloride in Dextrose Injection, USP 7.5 mg to 10.5 mg is generally adequate for Cesarean section. (2.2)",
    "warningsAndPrecautions_original": "Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F). [See USP Controlled Room Temperature.]\n                  Bupivacaine Hydrochloride in Dextrose Injection, USP solution may be autoclaved once at 15 pound pressure, 121\u00b0C (250\u00b0F) for 15 minutes. This product is clear and colorless. Do not use the solution if it is discolored or contains particulate matter.\n                  Single-dose ampules of 2 mL Bupivacaine Hydrochloride in Dextrose Injection, USP (15 mg bupivacaine hydrochloride with 165 mg dextrose) are supplied as follows:\n                  \n                     \n                     \n                     \n                        \n                           \u00a0Unit of Sale\n                           \n                           \u00a0Concentration\n                           \n                        \n                        \n                           \n                              NDC 0264-9379-88\n                               Carton of 10 single-dose ampules\n                           \u00a015 mg/2 mL (7.5 mg/mL)\n                        \n                     \n                  \n                  Discard the unused portion.",
    "adverseReactions_original": "Bupivacaine Hydrochloride in Dextrose Injection is contraindicated in:\n                  \n                     intravenous regional anesthesia (Bier Block) [see Warnings and Precautions (5.8)].\n                        \n                     \n                     patients with septicemia.\n                        \n                     \n                     patients with severe hemorrhage, severe hypotension or shock, due to a reduced cardiac output.\n                        \n                     \n                     patients with clinically significant arrhythmias, such as complete heartblock, due a reduced cardiac output.\n                        \n                     \n                     patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of Bupivacaine Hydrochloride in Dextrose Injection.\n                  \n                  \n                      patients with local infection at the site of proposed lumbar puncture.",
    "drug": [
        {
            "name": "Bupivacaine Hydrochloride with Dextrose",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3215"
        }
    ]
}